Modeling and simulation of the endogenous CYP3A induction marker 4β-hydroxycholesterol during enasidenib treatment

por Li, Yan, Connarn, Jamie N, Chen, Jian, Tong, Zeen, Palmisano, Maria, Zhou, Simon
Publicado 2019

Characterizing the exposure–response relationship of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma

por Connarn, Jamie N., Witjes, Han, van Zutphen‐van Geffen, Marielle, de Greef, Rik, Campbell, Timothy B., Hege, Kristen, Zhou, Simon, Lamba, Manisha
Publicado 2023

Identification of non‐reported bupropion metabolites in human plasma

por Connarn, Jamie N., Luo, Ruijuan, Windak, Jim, Zhang, Xinyuan, Babiskin, Andrew, Kelly, Marisa, Harrington, Gloria, Ellingrod, Vicki L., Kamali, Masoud, McInnis, Melvin, Sun, Duxin
Publicado 2016

Sotatercept Safety and Effects on Hemoglobin, Bone, and Vascular Calcification

por Coyne, Daniel W., Singh, Hem N., Smith, William T., Giuseppi, Ana Carolina, Connarn, Jamie N., Sherman, Matthew L., Dellanna, Frank, Malluche, Hartmut H., Hruska, Keith A.
Publicado 2019

Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citarinostat in Combination With Paclitaxel in Patients With Advanced Solid Tumors

por Gordon, Michael S., Shapiro, Geoffrey I., Sarantopoulos, John, Juric, Dejan, Lu, Brian, Zarotiadou, Angeliki, Connarn, Jamie N., Le Bruchec, Yvan, Dumitru, Calin Dan, Harvey, R. Donald
Publicado 2022

CC-99677, a novel, oral, selective covalent MK2 inhibitor, sustainably reduces pro-inflammatory cytokine production

por Gaur, Rajula, Mensah, Kofi A., Stricker, Jason, Adams, Mary, Parton, Anastasia, Cedzik, Dorota, Connarn, Jamie, Thomas, Michael, Horan, Gerald, Schafer, Peter, Mair, Stuart, Palmisano, Maria, Ramírez-Valle, Francisco
Publicado 2022

Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer

por Sun, Lichao, Burnett, Joseph, Gasparyan, Mari, Xu, Fangying, Jiang, Hui, Lin, Chang-Ching, Myers, Ila, Korkaya, Hasan, Liu, Yajing, Connarn, Jamie, He, Huining, Zhang, Ning, Wicha, Max S., Sun, Duxin
Publicado 2016

Trastuzumab resistance induces EMT to transform HER2(+) PTEN(−) to a triple negative breast cancer that requires unique treatment options

por Burnett, Joseph P., Korkaya, Hasan, Ouzounova, Maria D., Jiang, Hui, Conley, Sarah J., Newman, Bryan W., Sun, Lichao, Connarn, Jamie N., Chen, Ching-Shih, Zhang, Ning, Wicha, Max S., Sun, Duxin
Publicado 2015